CN Stock MarketDetailed Quotes
000504 Landfar Bio-medicine
- 10.31
- +0.16+1.58%
Trading Nov 8 13:57 CST
3.40BMarket Cap-92053P/E (TTM)
10.34High10.00Low66.19KlotVolume10.19Open10.15Pre Close67.29MTurnover2.13%Turnover RatioLossP/E (Static)330.02MShares12.3752wk High13.69P/B3.20BFloat Cap5.2652wk Low11.17Limit Up310.67MShs Float36.97Historical High9.14Limit Down3.35%Amplitude1.37Historical Low--Dividend TTM10.17Avg Price32.25KlotAsk--Div YieldTTM100Lot Size31.98KlotBid
Landfar Bio-medicine Key Stats
EPS
According to the latest financial report of Landfar Bio-medicine, the latest earnings per share (TTM) for the company is -0.03. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Landfar Bio-medicine's latest financial report to see how much their book value per share (BVPS) is currently at 0.75.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Landfar Bio-medicine shows that the company's current ratio is 1.83, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Landfar Bio-medicine, the quick ratio is 1.76, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Landfar Bio-medicine? The latest ROE figure is -3.33%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Landfar Bio-medicine, the total asset return on investment (ROA) is -1.30%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Landfar Bio-medicine's latest financial report to see how their gross margin is doing - currently at 68.03%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Landfar Bio-medicine, the net profit margin is -9.61%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data